Literature DB >> 11074481

Protective titres of measles neutralising antibody.

M S Lee1, D J Nokes, H M Hsu, C F Lu.   

Abstract

A nation-wide measles outbreak occurred in 1988 in Taiwan. A retrospective cohort study was conducted to define the protective titre of measles neutralising (NT) antibody. Paired sera collected in 1987 and 1988 were available from 190 individuals born in 1984 who had participated in an annual hepatitis B immunisation follow-up from 1986 to 1991. Measles NT titres were quantified using a standardised neutralisation enzyme immunoassay. Measles infection was defined as a >/=4-fold rise in NT titre or seroconversion between paired sera. Symptomatic measles infection was ascribed to individuals who had measles infection and who reported measles-like symptoms between 1987 and 1988. Results demonstrated a dose-response relationship between pre-exposure NT titres and protection against measles infection. 47 of 48 individuals with measles infection in 1988 had pre-exposure NT titres </=1,017 mIU/ml; all 12 symptomatic cases had pre-exposure NT titres </=434 mIU/ml. Eleven vaccinees had pre-exposure NT titres <50 mIU/ml, of whom nine developed asymptomatic infection. The study suggests that measles NT titres >1, 000 mIU/ml may prevent measles infection and NT titres >500 mIU/ml may prevent symptomatic infection but vaccinees with undetectable or low NT titres may not necessarily be susceptible to symptomatic infection. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11074481     DOI: 10.1002/1096-9071(200012)62:4<511::aid-jmv17>3.0.co;2-z

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  13 in total

1.  Modelling vaccination programmes against measles in Taiwan.

Authors:  S C Chen; C F Chang; L J Jou; C M Liao
Journal:  Epidemiol Infect       Date:  2006-10-26       Impact factor: 2.451

2.  Backward bifurcations and multiple equilibria in epidemic models with structured immunity.

Authors:  Timothy C Reluga; Jan Medlock; Alan S Perelson
Journal:  J Theor Biol       Date:  2008-01-26       Impact factor: 2.691

3.  Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia.

Authors:  A Tischer; N Andrews; G Kafatos; A Nardone; G Berbers; I Davidkin; Y Aboudy; J Backhouse; C Barbara; K Bartha; B Bruckova; A Duks; A Griskevicius; L Hesketh; K Johansen; L Jones; O Kuersteiner; E Lupulescu; Z Mihneva; M Mrazova; F De Ory; K Prosenc; F Schneider; A Tsakris; M Smelhausova; R Vranckx; M Zarvou; E Miller
Journal:  Epidemiol Infect       Date:  2007-03-30       Impact factor: 2.451

4.  Implication of health care personnel in measles transmission.

Authors:  Núria Torner; Ruben Solano; Cristina Rius; Angela Domínguez; The Measles Elimination Program Surveillance Network Of Catalonia Spain
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

5.  Long-Term Outcomes of Proximal Gastrectomy versus Total Gastrectomy for Upper-Third Gastric Cancer.

Authors:  Myoung Won Son; Yong Jin Kim; Gui Ae Jeong; Gyu Seok Cho; Moon Soo Lee
Journal:  J Gastric Cancer       Date:  2014-12-26       Impact factor: 3.720

6.  Comparison of the neutralizing and ELISA antibody titres to measles virus in human sera and in gamma globulin preparations.

Authors:  Holger F Rabenau; Branko Marianov; Sabine Wicker; Regina Allwinn
Journal:  Med Microbiol Immunol       Date:  2007-02-17       Impact factor: 3.402

7.  A chimeric human-bovine parainfluenza virus type 3 expressing measles virus hemagglutinin is attenuated for replication but is still immunogenic in rhesus monkeys.

Authors:  M H Skiadopoulos; S R Surman; J M Riggs; P L Collins; B R Murphy
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Immunogenicity of a recombinant measles-HIV-1 clade B candidate vaccine.

Authors:  Richard Stebbings; Michèle Février; Bo Li; Clarisse Lorin; Marguerite Koutsoukos; Edward Mee; Nicola Rose; Joanna Hall; Mark Page; Neil Almond; Gerald Voss; Frédéric Tangy
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

9.  Seroprevalence survey on measles, mumps, rubella and varicella antibodies in healthcare workers in Japan: sex, age, occupational-related differences and vaccine efficacy.

Authors:  S Kumakura; H Shibata; K Onoda; N Nishimura; C Matsuda; M Hirose
Journal:  Epidemiol Infect       Date:  2013-04-11       Impact factor: 2.451

10.  Impact of vaccination on measles, mumps, and rubella antibody titers in Japanese healthcare workers: An observational study.

Authors:  Taku Ogawa; Takashi Inoue; Kei Kasahara; Mitsuru Konishi; Keiichi Mikasa
Journal:  PLoS One       Date:  2020-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.